Subscribe to Bankless or sign in
Nasdaq-listed 180 Life Sciences has raised $425 million to create an Ethereum-focused treasury and is rebranding itself as ETHZilla, in partnership with institutional crypto investors and ecosystem leaders.
What’s the Scoop?
- Funding Raise: The company secured $425 million in a private investment in public equity (PIPE), led by more than 60 institutional and crypto-native investors including Polychain, Electric Capital, and GSR.
- Rebrand to ETHZilla: 180 Life Sciences will officially rebrand to ETHZilla Corporation upon closing around August 1.
- ETH Acquisition Plan: The majority of capital will be used to purchase and vest its treasury in Ethereum, managed externally by Electric Capital.
- On‑Chain Yield Strategy: ETHZilla will generate yield not only through staking but via a diversified on‑chain strategy—lending, liquidity provision, and structured protocols.
- Ecosystem Governance: A DeFi Council made up of protocol leaders (e.g. founders of Lido, EigenLayer, Compound) through partner Etherealize will advise on deployment and strategy.https://www.theblock.co/post/364668/180-life-sciences-ethereum-treasury-ethzilla
